Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 […]